Market Cap 152.68B
Revenue (ttm) 16.75B
Net Income (ttm) 1.85B
EPS (ttm) N/A
PE Ratio 38.47
Forward PE 35.63
Profit Margin 11.07%
Debt to Equity Ratio 0.50
Volume 5,890,200
Avg Vol 7,206,884
Day's Range N/A - N/A
Shares Out 1.48B
Stochastic %K 27%
Beta 0.68
Analysts Strong Sell
Price Target $120.50

Company Profile

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal sur...

Industry: Medical Devices
Sector: Healthcare
Phone: 508 683 4000
Address:
300 Boston Scientific Way, Marlborough, United States
Thelonius_Stonk
Thelonius_Stonk Jul. 12 at 12:31 PM
$BSX beast knocking knocking at ath. breakout here should give another nice leg higher. or you buys dips. longterm winner. period
0 · Reply
jewell69
jewell69 Jul. 11 at 6:26 PM
$BSX hard to make money on Boston scientific 7/11 buy re-entry b 80 103.06 Previous trades S 119 103.68 6/24 B 6/5 59 102.80 B 6/3 60 102.97
0 · Reply
ZacksResearch
ZacksResearch Jul. 11 at 4:54 PM
AI is transforming $BSX, $JNJ, and $GEHC — are these the 2025 winners? 🚀 Boston Scientific projects a 16.4% sales growth in 2025, driven by AI-powered diagnostics like HeartLogic and Rhythm AI, compared to the industry's flat growth. Johnson & Johnson's AI innovations in surgical robotics and digital analytics are set to boost its MedTech division, and GE HealthCare topped the FDA list with 80 AI-enabled device clearances. See why these stocks are positioned for AI-driven success 👉 https://www.zacks.com/stock/news/2573185/3-ai-driven-medical-device-stocks-to-watch-in-2025?cid=sm-stocktwits-2-2573185-body-1321&ADID=SYND_STOCKTWITS_TWEET_2_2573185_BODY_1321
0 · Reply
ZacksResearch
ZacksResearch Jul. 11 at 12:38 PM
AI + healthcare = massive upside? $BSX, $JNJ and $GEHC are tapping AI to enhance device performance, diagnostics, and surgical precision heading into 2025. See why these 3 could lead the medtech surge 👉 https://www.zacks.com/stock/news/2573185/3-ai-driven-medical-device-stocks-to-watch-in-2025?cid=sm-stocktwits-0-2573185-teaser-1281&ADID=SYND_STOCKTWITS_TWEET_0_2573185_TEASER_1281
0 · Reply
cheddar__
cheddar__ Jul. 10 at 8:30 PM
$EW $SYK $BSX $MDT $ABT Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older patients https://bbtw.cheddar.com/p/medtech-stocks-defy-spending-cuts-and-soar
0 · Reply
ZacksResearch
ZacksResearch Jul. 10 at 2:48 PM
$BSX up 33.6% in a year — what's fueling the momentum? 🚀 The MedSurg segment is gaining market share, while WATCHMAN sales increased 24% in Q1 2025 and strategic acquisitions contributed 400 basis points to growth, boosting long-term prospects. See why this Zacks Rank #2 stock could be a solid play 👉 https://www.zacks.com/stock/news/2570793/is-it-worth-adding-boston-scientific-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2570793-body-1179&ADID=SYND_STOCKTWITS_TWEET_2_2570793_BODY_1179
0 · Reply
ZacksResearch
ZacksResearch Jul. 10 at 11:39 AM
$BSX riding a quiet uptrend — but is it time to buy? MedSurg strength and smart acquisitions are fueling growth, even as currency headwinds linger. Find out if BSX deserves a spot in your portfolio 👉 https://www.zacks.com/stock/news/2570793/is-it-worth-adding-boston-scientific-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2570793-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2570793_TEASER
0 · Reply
Quantumup
Quantumup Jul. 9 at 1:08 PM
Stephens🏁 $PRCT Overweight-$70 and said "Premium Price, Premium Potential: A Surgical Disruptor in BPH; Initiating OW-Vol./$70 PT" $BSX $ISRG $SYK $MDT #BPH #PCa Stephens said in its note that it expects $PRCT to post robust growth and margin expansion as adoption of Aquablation continues to expand. Stephens added: ● Aquablation is disrupting the benign prostatic hyperplasia (BPH) market by taking share from existing procedures and capturing patients who historically delayed or avoided surgery. ● Believes expanding into prostate cancer has the potential to drive meaningful growth longer-term.
0 · Reply
ElliottwaveForecast
ElliottwaveForecast Jul. 9 at 7:41 AM
$BSX broke to new highs from the #bluebox area as expected from May-2025 update Next pullback in 3, 7, or 11 swings should remain supported to rally toward 112+ https://elliottwave-forecast.com/stock-market/bsx-navigating-market-trends-price-action/ #Elliottwave #Stocks
0 · Reply
maestro_of_the_markets
maestro_of_the_markets Jul. 8 at 3:30 PM
$IINN wake me when $BSX comes with the tender offer, or this trades 100 million shares, have a great day all! Find something else to do with your time. A watched pot never boils! 🤔
1 · Reply
Latest News on BSX
I'm Buying Dividend Aristocrats At Bargain Basement Prices

Jun 17, 2025, 8:00 AM EDT - 25 days ago

I'm Buying Dividend Aristocrats At Bargain Basement Prices

JNJ KO MDT PEP


What's Happening With Boston Scientific Stock?

Jun 16, 2025, 11:00 AM EDT - 26 days ago

What's Happening With Boston Scientific Stock?


3 Growth Stocks That Aren't the Magnificent 7

Jun 6, 2025, 2:42 PM EDT - 5 weeks ago

3 Growth Stocks That Aren't the Magnificent 7

CYBR


Boston Scientific announces results for first quarter 2025

Apr 23, 2025, 6:30 AM EDT - 2 months ago

Boston Scientific announces results for first quarter 2025


Boston Scientific announces agreement to acquire SoniVie Ltd.

Mar 3, 2025, 6:58 AM EST - 4 months ago

Boston Scientific announces agreement to acquire SoniVie Ltd.


What's Behind The 130% Rise In BSX Stock?

Feb 12, 2025, 7:00 AM EST - 5 months ago

What's Behind The 130% Rise In BSX Stock?


Top 4 Health Care Stocks You May Want To Dump In Q1

Jan 21, 2025, 6:06 AM EST - 6 months ago

Top 4 Health Care Stocks You May Want To Dump In Q1

BBIO ISRG ITCI


Boston Scientific Jumps Ahead of Earnings

Jan 15, 2025, 6:10 AM EST - 6 months ago

Boston Scientific Jumps Ahead of Earnings


Thelonius_Stonk
Thelonius_Stonk Jul. 12 at 12:31 PM
$BSX beast knocking knocking at ath. breakout here should give another nice leg higher. or you buys dips. longterm winner. period
0 · Reply
jewell69
jewell69 Jul. 11 at 6:26 PM
$BSX hard to make money on Boston scientific 7/11 buy re-entry b 80 103.06 Previous trades S 119 103.68 6/24 B 6/5 59 102.80 B 6/3 60 102.97
0 · Reply
ZacksResearch
ZacksResearch Jul. 11 at 4:54 PM
AI is transforming $BSX, $JNJ, and $GEHC — are these the 2025 winners? 🚀 Boston Scientific projects a 16.4% sales growth in 2025, driven by AI-powered diagnostics like HeartLogic and Rhythm AI, compared to the industry's flat growth. Johnson & Johnson's AI innovations in surgical robotics and digital analytics are set to boost its MedTech division, and GE HealthCare topped the FDA list with 80 AI-enabled device clearances. See why these stocks are positioned for AI-driven success 👉 https://www.zacks.com/stock/news/2573185/3-ai-driven-medical-device-stocks-to-watch-in-2025?cid=sm-stocktwits-2-2573185-body-1321&ADID=SYND_STOCKTWITS_TWEET_2_2573185_BODY_1321
0 · Reply
ZacksResearch
ZacksResearch Jul. 11 at 12:38 PM
AI + healthcare = massive upside? $BSX, $JNJ and $GEHC are tapping AI to enhance device performance, diagnostics, and surgical precision heading into 2025. See why these 3 could lead the medtech surge 👉 https://www.zacks.com/stock/news/2573185/3-ai-driven-medical-device-stocks-to-watch-in-2025?cid=sm-stocktwits-0-2573185-teaser-1281&ADID=SYND_STOCKTWITS_TWEET_0_2573185_TEASER_1281
0 · Reply
cheddar__
cheddar__ Jul. 10 at 8:30 PM
$EW $SYK $BSX $MDT $ABT Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older patients https://bbtw.cheddar.com/p/medtech-stocks-defy-spending-cuts-and-soar
0 · Reply
ZacksResearch
ZacksResearch Jul. 10 at 2:48 PM
$BSX up 33.6% in a year — what's fueling the momentum? 🚀 The MedSurg segment is gaining market share, while WATCHMAN sales increased 24% in Q1 2025 and strategic acquisitions contributed 400 basis points to growth, boosting long-term prospects. See why this Zacks Rank #2 stock could be a solid play 👉 https://www.zacks.com/stock/news/2570793/is-it-worth-adding-boston-scientific-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2570793-body-1179&ADID=SYND_STOCKTWITS_TWEET_2_2570793_BODY_1179
0 · Reply
ZacksResearch
ZacksResearch Jul. 10 at 11:39 AM
$BSX riding a quiet uptrend — but is it time to buy? MedSurg strength and smart acquisitions are fueling growth, even as currency headwinds linger. Find out if BSX deserves a spot in your portfolio 👉 https://www.zacks.com/stock/news/2570793/is-it-worth-adding-boston-scientific-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2570793-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2570793_TEASER
0 · Reply
Quantumup
Quantumup Jul. 9 at 1:08 PM
Stephens🏁 $PRCT Overweight-$70 and said "Premium Price, Premium Potential: A Surgical Disruptor in BPH; Initiating OW-Vol./$70 PT" $BSX $ISRG $SYK $MDT #BPH #PCa Stephens said in its note that it expects $PRCT to post robust growth and margin expansion as adoption of Aquablation continues to expand. Stephens added: ● Aquablation is disrupting the benign prostatic hyperplasia (BPH) market by taking share from existing procedures and capturing patients who historically delayed or avoided surgery. ● Believes expanding into prostate cancer has the potential to drive meaningful growth longer-term.
0 · Reply
ElliottwaveForecast
ElliottwaveForecast Jul. 9 at 7:41 AM
$BSX broke to new highs from the #bluebox area as expected from May-2025 update Next pullback in 3, 7, or 11 swings should remain supported to rally toward 112+ https://elliottwave-forecast.com/stock-market/bsx-navigating-market-trends-price-action/ #Elliottwave #Stocks
0 · Reply
maestro_of_the_markets
maestro_of_the_markets Jul. 8 at 3:30 PM
$IINN wake me when $BSX comes with the tender offer, or this trades 100 million shares, have a great day all! Find something else to do with your time. A watched pot never boils! 🤔
1 · Reply
hyenacorp
hyenacorp Jul. 8 at 1:58 PM
$BSX barely holding
2 · Reply
Reanimated666
Reanimated666 Jul. 8 at 11:16 AM
0 · Reply
maestro_of_the_markets
maestro_of_the_markets Jul. 7 at 6:53 PM
$IINN who knew that sales was the cure for all in an upstart disruptive tech company in a $19 Billion industry? 🤷🏼‍♂️. Like all disruptive tech, the sales should come easily as the value proposition should be clear to almost everyone! This industry is still using 1950s and 1960s technology! 🤔. Think I will hold for the $BSX buyout, or when it trades 100 million shares in one day! Which ever comes first! 😉
1 · Reply
Ravenskys1
Ravenskys1 Jul. 7 at 3:11 PM
$BSX 🚀 https://stocks.apple.com/AVi2-x78_RwieA2ARedzeQg
0 · Reply
maestro_of_the_markets
maestro_of_the_markets Jul. 7 at 2:42 PM
$IINN tomorrow’s meeting will expand or market likely into the Middle East or South East Asia! If it results in anything near another $20 million order, this thing won’t make the ART500 FDA deadline because it will be picked off by $BSX or another med equipment manufacturer quickly! If they wait too long it will be billions instead of hundreds of millions. JMHO enjoy the rest of your day everyone! 💪🏿😈💯❤️
1 · Reply
Reanimated666
Reanimated666 Jul. 7 at 2:15 PM
$BSX Long some
0 · Reply
maestro_of_the_markets
maestro_of_the_markets Jul. 7 at 12:57 PM
$IINN I am actually starting to think I underestimate the value of a buyout here at $300-500 million based on the potential! If I use the same 9 x sales as $BSX, this one order alone makes the current value $200 million, and more to come. This excludes the $540 million of pre orders for ART500 and HYLA. I am now thinking $700 million to $1 Billion on a buyout is more realistic and $300 to $500 million on market next 12-18 months more like it. 💪🏿😈💯❤️
0 · Reply
G_krupins
G_krupins Jul. 6 at 4:25 PM
$BSX needs time but like how it's shaping up. Alert at line
0 · Reply
maestro_of_the_markets
maestro_of_the_markets Jul. 3 at 12:02 PM
$IINN Here is some more DD. $BSX trades at an 80 trailing p/e and a 40 forward p/e, and a p/s of 8 to 9. That would currently value this company at $7.85! Based on one order! Have a great day everyone! 💪🏿😈💯❤️
0 · Reply
maestro_of_the_markets
maestro_of_the_markets Jul. 3 at 11:52 AM
$IINN just wake me up when the $BSX tender offer comes in would yah, I will right over here!
0 · Reply
maestro_of_the_markets
maestro_of_the_markets Jul. 3 at 11:35 AM
$IINN this message is for all the OGs here that I can barely see because of all these pumpers! I have one thing to say today! $540 million of ART500 preorder LOIs are legit now. Will happily take a 1 times revenue deal from $BSX. Have a great day all. Woke up to a wet dock, can’t seal it today. 💪🏿😈💯❤️
0 · Reply
maestro_of_the_markets
maestro_of_the_markets Jul. 2 at 8:26 PM
$IINN $BSX buyout! 12-18 months tops! 🤫
1 · Reply